Scientists have overcome a key barrier to self-amplifying vaccines. The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable. saRNA vaccines hold great promise but are hindered by an inherent flaw which undermines their effectiveness.
Included as a benefit
Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.
Find out more about how to join.
FREE
Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.
3.75 per month / £35 annually
Get unlimited access to The Microbiologist.